- Erratum
- Open access
- Published:
Erratum to: The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials
Critical Care volume 18, Article number: 436 (2014)
The Original Article was published on 09 January 2014
After publication of our article in a recent issue of Critical Care[1], inconsistencies were identified in Figure 6. Four trials - by Fuentes-Orozco and colleagues [2, 3], Hall and colleagues [4], and Goeters and colleagues [5] - were allocated to the wrong subgroup in our meta-analysis. They should have been included in the first subgroup (glutamine <0.3 g/kg per day); this does not change the significance of the results (P = 0.01). The correct Figure 6 is given here in full as Figure 1.
A subgroup meta-analysis of the effects of different dosages of glutamine on mortality in critically ill patients (fixed effects models). CI, confidence interval; M-H, Mantel-Haenszel.
References
Chen QH, Yang Y, He HL, Xie JF, Cai SX, Liu AR, Wang HL, Qiu HB: The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Crit Care. 2014, 18: R8-10.1186/cc13185.
Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A, Arenas-Márquez H, Cabrera-Pivaral C, Cervantes-Guevara G, Barrera-Zepeda LM: L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004, 23: 13-21. 10.1016/S0261-5614(03)00055-4.
Fuentes-Orozco C, Cervantes-Guevara G, Muciño-Hernández I, López-Ortega A, Ambriz-González G, Gutiérrez-de-la-Rosa JL, Gómez-Herrera E, Hermosillo-Sandoval JM, González-Ojeda A: L-alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr. 2008, 32: 403-411. 10.1177/0148607108319797.
Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R: A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med. 2003, 29: 1710-1716. 10.1007/s00134-003-1937-2.
Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone HG: Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002, 30: 2032-2037. 10.1097/00003246-200209000-00013.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
The authors declare that they have no competing interests.
The online version of the original article can be found at 10.1186/cc13185
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
About this article
Cite this article
Chen, QH., Yang, Y., He, HL. et al. Erratum to: The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Crit Care 18, 436 (2014). https://doi.org/10.1186/cc13926
Published:
DOI: https://doi.org/10.1186/cc13926